• Daali Y, Ancrenaz V, Bosilkovska M, Dayer P,  Desmeules J : Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug–drug interaction in HIV patients. Metabolism. 2011;60:1584-9.
  
  
• L’Huillier AG, K Ing Lorenzini K, Crisinel P-A, Rebsamen MC, Fluss J, Korff CM, Barbe RP, Siegrist C-A, Dayer P, Posfay-Barbe KM,  Desmeules J : ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia. Pharmacogenomics. 2011; (in press).
  
  
• Ing Lorenzini K, Besson M, Daali Y, Salomon D, Dayer P, Desmeules J : A Randomized, Controlled Trial Validates a Peripheral Supra-Additive Antihyperalgesic Effect of a Paracetamol–Ketorolac Combination. Basic Clin Pharmacol Toxicol. 2011;109:357-64.
  
  
• Ancrenaz V, Daali Y, Fontana P, Besson M, Samer C, Dayer P,  Desmeules J : Impact of Genetic Polymorphisms and Drug–Drug Interactions on Clopidogrel and Prasugrel Response Variability. Curr Drug Metab 2010;11:667-77.
  
  
• Déglon J, Thomas A, Daali Y, Lauer E, Samer C, Desmeules J, Dayer P, Mangin P, Staub C : Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite. J Pharm Biomed Anal 2011; 25:359-67.
  
  
• Samer C, Daali Y, Wagner M, Hopfgartner G, Eap C, Rebsamen M, Rossier M, Hochstrasser D, Dayer P, Desmeules J : The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone. Brit J Pharmacol 2010; 160: 907-18.
  
  
• Samer C, Daali Y, Wagner M, Hopfgartner G, Eap C, Rebsamen M, Rossier M, Hochstrasser D, Dayer P, Desmeules J : Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy. Brit J Pharmacol 2010; 160: 919-30.
  
  
• Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R : Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates (A Case Series from a Swiss University Hospital). Drug Safety 2009; 32: 775-85.
  
  
• Kanaan M, Daali Y, Dayer P, Desmeules J. : P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone. Fundam Clin Pharmacol 2009; 23: 543-8.
  
  
• Kanaan M, Daali Y, Dayer P, Desmeules J. : Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein. Basic Clin Pharmacol Toxicol 2009; 105: 199-206.
  
  
• Ansermot N, Rebsamen M, Chabert J, Fathi M, Gex-Fabry M, Daali Y, Besson M, Rossier M, Rudaz S, Hochstrasser D, Dayer P, Desmeules J : Influence of ABCB1 Gene Polymorphisms and P-Glycoprotein Activity on Cyclosporine Pharmacokinetics in Peripheral Blood Mononuclear Cells in Healthy Volunteers. Drug Metabolism Letters 2008; 2: 76-82.
  
  
• Ing-Lorenzini K, Desmeules J, Besson M, Veuthey JL, Dayer P, Dalli Y : Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study. J Chromatogr A 2009; 1216: 3851-86.
  
  
• Rollason V, Samer C, Piguet V, Dayer P, Desmeules J : Pharmacogenetics of analgesics: toward the individualization of prescription. Pharmacogenomics 2008; 9: 905-33.
  
  
• Rebsamen MC, Desmeules J, Daali Y, Chiappe A, Diemand A, Rey C, Chabert J, Dayer P, Hochstrasser D, Rossier MF : The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction. Pharmacogenomics J 2009; 9: 34-41.
  
  
• Kanaan M, Daali Y, Dayer P, Desmeules J : Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoprotein. Curr Drug Metab. 2008; 9: 144-51.
  
  
• Daali Y, Cherkaoui S, Doffey-Lazeyras F, Dayer P, Desmeules J : Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 86: 156-63.
  
  
• Lutters M, Vogt-Ferrier N : Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women (Review). Cochrane Database Syst Rev. 2008;3:CD001535.
  
  
• Escher M, Daali Y, Chabert J, Hopfgartner G, Dayer P, Desmeules J : Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled. Clin Ther 2007; 29: 1620-31.
  
  
• Mannion AF, Balagué F, Pellisé F, Cedraschi C : Pain measurements in patients with low back pain. Nat Clin Pract Rheumatol 2007; 3: 610-8.
  
  
• Ansermot N, Fathi M, Veuthey J-L, Desmeules J, Hochstrasser D, Rudaz S : Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 857: 92-9.
  
  
• Piguet V, Cedraschi C, Dumont P, Desmeules J, Allaz A-F, Dayer P : Patients' representations of antidepressants: a clue to nonadherence? Clin J Pain 2007; 23: 669-75.
  
  
• Luthy C, Cedraschi C, Rutschmann OT, Kossovsky MP, Allaz A-F : Managing postacute hospital care : A case for biopsychosocial needs. J Psychosom Res 2007; 62: 513-9.
  
  
• Girardin F, Gaspoz J-M : Surveillance de l'intervalle QT chez le patient psychiatrique. Rev Med Suisse 2007; 3: 945-8.
  
  
• Girardin F, Sztajzel J : Cardiac adverse reactions associated with psychotropic drugs. Dialogues Clin Neurosci 2007 (Poster): 92-5.
  
  
• Balagué F, Mannion AF, Pellisé F, Cedraschi C: Clinical update: low back pain. Lancet 2007; 369: 726-8.
  
  
• Girardin F : Membrane transporter proteins: a challenge for CNS drug development. Dialogues Clin Neurosci 2006; 8: 311-21.
  
  
• Balagué F, Cedraschi C : Radiological examination in low back pain patient:Anxiety of the patient? Anxiety of the therapist? Joint Bone Spine 2006; 73: 508-13.
  
  
• Ehret GB, Voide K, Gex-Fabry M, Chabert J, Shah D, Broers B, Piguet V, Musset T, Gaspoz J-M, Perrier A, Dayer P, Desmeules JA : Drug-induced long QT syndrome in injection drug users receiving methadone. Arch Intern Med 2006; 166: 1280-7.
  
  
• Vuilleumier N, Rossier MF, Chiappe A, Degoumois F, Dayer P, Mermillod B, Nicod L, Desmeules J, Hochstrasser D : CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur J Clin Pharmacol 2006; 62: 423-9.
  
  
• Henrotin YE, Cedraschi C, Duplan B, Bazin T, Duquesnoy B: Information and low back pain management: a systematic review. Spine 2006 ; 31: E326-34. Review
  
  
• Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G : Chapter 4. European guidelines for the management of chronic nonspecific low back pain.
  Eur Spine J. 2006 ;15 Suppl 2: S192-300.
  
  
• Nordin F, Balagué F, Cedraschi C : Nonspecific lower-back pain : surgical versus nonsurgical treatment. Clin Orthop Relat Res. 2006 ; 443: 156-67. Review
  
• Chassot P, Piguet V, Remund C, Luthy C, Cedraschi C : Douleurs chroniques et thérapie cognitivo-comportementale de groupe. Le courrier de l'algologie. 2006: 7-10.
  
  
• Ehret GB, Deluze C, Dayer P, Desmeules JA : Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasone. Eur J Intern Med 2005; 16: 612-4.
  
  
• Samer C, Piguet V, Dayer P, Desmeules JA : Polymorphisme génétique et interactions médicamenteuses : leur importance dans le traitement de la douleur [Genetic polymorphism and drug interactions: their importance in the treatment of pain]. Can J Anesth 2005; 52: 806-21.
  
  
• Girardin F, Pechère-Bertschi A : Traitement de l’hypertension artérielle et interactions médicamenteuses. Rev Med Suisse 2005; 1: 2099-104.
  
  
• Besson M, Brook P, Chizh BA, Pickering AE : Tactile allodynia in patients with postherpetic neuralgia: Lack of change in skin blood flow upon dynamic stimulation. Pain 2005; 117: 154-61.
  
  
• Sebo P, Pechere A, Desmeules JA, Dayer P : Treating hypertension: a challenge for the practioner. Rev Med Suisse 2005; 1: 934-8.
  
  
• Girardin F, Desmeules JA, Dayer P : Sélection d’un médicament dans une classe thérapeutique donnée : l’exemple des «inhibiteurs de l’HMG-CoA réductase». Rev Med Suisse 2005; 1: 949-53.
  
  
• Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J : Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004; 351: 2827-31.
  
  
• Escher M, Perneger TV, Chevrolet J-C : National questionnaire survey on what influences doctors’ decisions about admission to intensive care. BMJ 2004; 329: 425-30.
  
  
• Jerdi MC, Daali Y, Oestreicher MK, Cherkaoui S, Dayer P: A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes. J Pharm Biomed Anal. 2004 Sep 3;35(5):1203-12.
  
  
• Piguet V, Desmeules J, Ehret G, Stoller R, Dayer P: QT interval prolongation in patients on methadone with concomitant drugs. J Clin Psychopharmacol. 2004 Aug;24(4):446-8.
  
  
• Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL: Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis. 2004 Mar; 63:290-6.
  
  
• Desmeules J, Piguet V, Dayer P: Développement pharmacologique rationnel des associations d’analgésiques. Rev Rhum (éd. fr.) 2003; 69: hors-série n°1.
  
• Girardin F, Siegenthaler M, De Moerloose P, Desmeules J : Rofecoxib interaction with oral anticoagulant acenocoumarol. Eur J Clin Pharmacol 2003;59:489-90.
  
  
• Desmeules J, Rollason V, Piguet V, Dayer P : Clinical pharmacology and rationale of analgesic combinations. Eur J Anaesthesiol 2003; 20 (Suppl 28): 7-12.
  
  
• Desmeules J, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, Dayer P, Vischer TL : Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003; 48: 1420-9.
  
  
• Bertoli R, Girardin F, Russmann S, Lauterburg BH : Raynaud’s phenomenon induced by drugs acting on neurotransmission : two cases under reboxetine and one under tegaserod. Eur J Clin Pharmacol 2003;58:717.
  
  
• Cedraschi C, Desmeules J, Luthy C, Allaz A.-F : Aspects psychologiques de la fibromyalgie. Revue du rhumatisme 2003;70:331-6.
  
  
• Desmeules J, Cedraschi C, Piguet V, Allaz A.-F, Dayer P : Advances with analgesics and non-steroidal inflammatory drugs for the treatment of spinal disorders. Best Pract Res Clin Rheumatol 2002; 16: 105-21.

 top

Dernière modification le 01/11/2011